Introduction: GMP-Grade PLGA for Phase II/III Clinical Supply is a critical CMC decision for pharmaceutical companies developing long-acting injectables, microspheres, […]
Introduction Accelerating Health Canada ANDS Submission timelines requires a coordinated regulatory strategy that integrates pre-filing bioequivalence data verification, technical auditing
Introduction Bioanalytical Method Development and Validation at a CDMO provides the quantitative foundation needed to establish pharmacokinetic equivalence between generic
Introduction Engineering a Cell-Penetrating Peptide Conjugate provides a strategy for the non-invasive delivery of therapeutic antisense oligonucleotides across the blood-brain
Introduction: Sterility & Endotoxin Testing for Dexamethasone Injection is a critical quality-control activity for demonstrating the microbiological safety of an
Sterility & Endotoxin Testing for Dexamethasone Injection Read More »
Introduction Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) is a high-resolution, solution-phase analytical technique that enables dynamic characterization of backbone hydrogen-bonding patterns
Introduction Acceptable Intake (AI) Limits for Nitrosamines Calculation is performed through linear low-dose extrapolation using rodent TD50 carcinogenicity bioassays or
Introduction: Host Cell Protein Analysis for Biosimilars sits at the intersection of process development and regulatory strategy, since residual host-cell
Host Cell Protein (HCP) Analysis Service for Biosimilars: ELISA and LC-MS/MS Methods Read More »
Introduction: The BPOG Guidelines for Single-Use Systems and ICH Q3E are increasingly important because biopharmaceutical manufacturing relies heavily on polymeric
BioPhorum (BPOG) Guidelines for Single-Use Systems: How They Align with ICH Q3E Read More »
Introduction: Therapeutic peptide characterization for NDA and ANDA submissions sits at the intersection of analytical chemistry and regulatory strategy, and
